Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DepoCyte pharmacokinetics in cerebrospinal fluid and plasma after intrathecal administration in children with malignant brain tumors and leptomeningeal dissemination
2006-004982-32Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Feb 2007
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liposomal cytarabine in brain neoplasm, sponsored by Medical University of Vienna. Primary endpoint: Pharmacokinetics of liposomal cytarabine in CSF of infants with brain malignancy. Started Feb 2007; status: completed.
02
Drugs
liposomal cytarabine
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on 2006-004982-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004982-32.